抗体设计和开发中的人工智能:利用计算方法的力量
Soudabeh Kavousipour1, Mahdi Barazesh2, Shiva Mohammadi3
1Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Medical & biological engineering & computing
|August 31, 2025
概括
人工智能 (AI) 正在通过加速发现,优化治疗特性,并使新的抗体产生革命性变化. 这种转变有望产生更快,更有效的抗体制药.
科学领域:
- 生物技术和制药科学
- 计算生物学和生物信息学
- 免疫学和药物发现
背景情况:
- 抗体是针对性疾病干预的关键疗法.
- 传统的抗体设计方法效率低下,成本高昂,范围有限.
- 高通量数据生成为计算方法创造了新的机会.
研究的目的:
- 突出人工智能对抗体发展的变革性影响.
- 展示AI如何增强抗体序列设计,结构预测和优化.
- 展示人工智能在加速药物发现,目标识别和候选者优先级方面的作用.
主要方法:
- 机器学习,深度学习和强化学习算法的应用.
- 使用计算方法快速生成库和高效选.
- 将人工智能与实验方法集成为新的多功能抗体开发.
主要成果:
- 人工智能显著改善了抗体序列设计,3D结构预测,亲和力和特异性.
- 计算方法减少了实验需求,并支持提高免疫反应的理性设计.
- 人工智能通过分析大数据集和预测相互作用来加快药物候选者的识别和优先级.
结论:
- 人工智能正在彻底改变抗体开发,克服传统方法的局限性.
- 人工智能有助于创建具有增强有效性和安全性的新型多功能抗体.
- 人工智能领域的持续研究有望进一步改变制药业和治疗抗体领域.
相关概念视频
Hybridoma Technology
15.3K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.3K
Antibody Structure
61.2K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
61.2K


